Integrative Molecular Phenotyping
INTEGRATIVE MOLECULAR
PHENOTYPING
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY
DEPARTMENT OF MEDICAL
BIOCHEMISTRY AND BIOPHYSICS
WHEELOCK LABORATORY

Metabolomics News

US companies partner to investigate metabolomics of Alzheimer's disease - separationsNOW.com (press release)

Mon, 18/07/2016 - 17:27
US companies partner to investigate metabolomics of Alzheimer's diseaseseparationsNOW.com (press release)Muses Labs is partnering with Metabolon, a US metabolomics company, to investigate metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's disease. The companies expect to bring new clinical trial services and ...Muses Labs, Metabolon to study early-onset cognitive decline at molecular levelLong Term Livingall 2 news articles »

US companies partner to investigate metabolomics of Alzheimer's disease - separationsNOW.com

Mon, 18/07/2016 - 17:27
US companies partner to investigate metabolomics of Alzheimer's diseaseseparationsNOW.comMuses Labs is partnering with Metabolon, a US metabolomics company, to investigate metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's disease. The companies expect to bring new clinical trial services and ...Muses Labs, Metabolon to study early-onset cognitive decline at molecular levelLong Term Livingall 2 news articles »

US companies partner to investigate metabolomics of Alzheimer's disease - separationsNOW.com (press release)

Mon, 18/07/2016 - 17:27
US companies partner to investigate metabolomics of Alzheimer's diseaseseparationsNOW.com (press release)Muses Labs is partnering with Metabolon, a US metabolomics company, to investigate metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's disease. The companies expect to bring new clinical trial services and ...Muses Labs, Metabolon to study early-onset cognitive decline at molecular levelLong Term Livingall 2 news articles »

US companies partner to investigate metabolomics of Alzheimer's disease - separationsNOW.com

Mon, 18/07/2016 - 17:27
US companies partner to investigate metabolomics of Alzheimer's diseaseseparationsNOW.comMuses Labs is partnering with Metabolon, a US metabolomics company, to investigate metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's disease. The companies expect to bring new clinical trial services and ...

Metabolon and Muses Lab Partner to Advance Platform for Treatment of Early Alzheimer's - Alzheimer's News Today

Fri, 15/07/2016 - 17:55
Alzheimer's News TodayMetabolon and Muses Lab Partner to Advance Platform for Treatment of Early Alzheimer'sAlzheimer's News TodayMetabolomics measures changes in levels of metabolites (small molecules) and maps them to specific biochemical pathways to give clinicians a better understanding of a person's overall health and the influence of on health of genes, microbiome, diet, ...and more »

Metabolon, Muses Labs team up to apply metabolomics to Alzheimer's disease - pharmabiz.com

Fri, 15/07/2016 - 12:36
Alzheimer's News TodayMetabolon, Muses Labs team up to apply metabolomics to Alzheimer's diseasepharmabiz.comMuses Labs has partnered with Metabolon, Inc., the global leader in metabolomics, to study and apply metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's disease. The companies expect to bring new clinical trial ...Metabolon and Muses Lab Partner to Advance Platform for Treatment of Early Alzheimer'sAlzheimer's News Todayall 2 news articles »

Metabolon, Muses Labs team up to apply metabolomics to Alzheimer's disease - pharmabiz.com

Fri, 15/07/2016 - 12:36
Metabolon, Muses Labs team up to apply metabolomics to Alzheimer's diseasepharmabiz.comMuses Labs has partnered with Metabolon, Inc., the global leader in metabolomics, to study and apply metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's disease. The companies expect to bring new clinical trial ...

Get SMART – novel metabolomics analysis tool - Biotechin.Asia

Fri, 15/07/2016 - 07:34
Biotechin.AsiaGet SMART – novel metabolomics analysis toolBiotechin.AsiaMetabolomics is the large-scale study of small molecules, commonly known as metabolites, within cells, biofluids, tissues or organisms. Collectively, these small molecules and their interactions within a biological system are known as the metabolome.

Global Metabolomics Market Will Growing at CAGR of Around 25.0% Between 2015 and 2020 - Digital Journal

Thu, 14/07/2016 - 17:08
Global Metabolomics Market Will Growing at CAGR of Around 25.0% Between 2015 and 2020Digital JournalDeerfield Beach, FL -- (SBWIRE) -- 07/14/2016 -- Zion Research has published a new report titled "Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and ...

Muses Labs Partners With Metabolon on Metabolomics of Cognitive Decline, Alzheimer's Disease - GenomeWeb

Wed, 13/07/2016 - 18:18
Muses Labs Partners With Metabolon on Metabolomics of Cognitive Decline, Alzheimer's DiseaseGenomeWebNEW YORK (GenomeWeb) – Muses Labs announced today that it has formed a partnership with Metabolon to research the metabolomics of pre- and early-symptomatic cognitive decline and Alzheimer's disease. Muses Labs currently markets a protocol ...Metabolon and Muses Labs Partner to Apply Metabolomics to Alzheimer's DiseaseBusiness Wire (press release)all 2 news articles »

Metabolon and Muses Labs Partner to Apply Metabolomics to Alzheimer's Disease - Business Wire (press release)

Wed, 13/07/2016 - 15:55
Metabolon and Muses Labs Partner to Apply Metabolomics to Alzheimer's DiseaseBusiness Wire (press release)RALEIGH, N.C.--(BUSINESS WIRE)--Muses Labs announced today it has partnered with Metabolon, Inc., the global leader in metabolomics, to study and apply metabolomics in individuals with pre- and early-symptomatic cognitive decline and Alzheimer's ...and more »

Metabolomics Signature Can Predict Transition From Gestational Diabetes to Type 2 Diabetes - Endocrinology Advisor

Fri, 01/07/2016 - 00:17
Metabolomics Signature Can Predict Transition From Gestational Diabetes to Type 2 DiabetesEndocrinology Advisor(HealthDay News) — A metabolomics signature can predict the transition from gestational diabetes to type 2 diabetes, according to a study published in Diabetes. Amina Allalou, from the University of Toronto, and colleagues enrolled a prospective ...and more »

Metabolomics Signature Can Predict GDM to T2DM Transition - Doctors Lounge

Thu, 30/06/2016 - 19:05
Metabolomics Signature Can Predict GDM to T2DM TransitionDoctors LoungeTHURSDAY, June 30, 2016 (HealthDay News) -- A metabolomics signature can predict the transition from gestational diabetes mellitus (GDM) to type 2 diabetes (T2D), according to a study published online June 23 in Diabetes. Amina Allalou, from the ...

Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a ... - UroToday

Thu, 30/06/2016 - 09:16
Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a ...UroTodayInterstitial cystitis/bladder pain syndrome (IC/BPS) is a poorly understood syndrome affecting up to 6.5% of adult women in the U.S. The lack of broadly accepted objective laboratory markers for this condition hampers efforts to diagnose and treat this ...and more »

Vitamins, metabolomics, and prostate cancer. - UroToday

Mon, 27/06/2016 - 17:22
Vitamins, metabolomics, and prostate cancer.UroTodayProstate cancer risk data related to vitamins E, A, and D and metabolomic profiling from clinical, cohort, and nested case-control studies, along with randomized controlled trials, are examined and summarized, along with recent metabolomic data of the ...and more »

Vitamins, metabolomics, and prostate cancer. - UroToday

Mon, 27/06/2016 - 17:22
Vitamins, metabolomics, and prostate cancer.UroTodayProstate cancer risk data related to vitamins E, A, and D and metabolomic profiling from clinical, cohort, and nested case-control studies, along with randomized controlled trials, are examined and summarized, along with recent metabolomic data of the ...and more »

United States Metabolomics Industry 2016 : ABCAM, AGILENT TECHNOLOGIES INC., ATHEROTECH DIAGNOSTICS ... - Medgadget.com (blog)

Mon, 27/06/2016 - 08:48
United States Metabolomics Industry 2016 : ABCAM, AGILENT TECHNOLOGIES INC., ATHEROTECH DIAGNOSTICS ...Medgadget.com (blog)QY-Research-Groups625 The United States Metabolomics Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Metabolomics industry. Top Manufacturers Analysis of Metabolomics :- ABCAM, AGILENT ...

Global Metabolomics Market Trends, Growth, Company Share To 2021: Acute Market Reports - RD News Mag

Sun, 26/06/2016 - 09:01
Global Metabolomics Market Trends, Growth, Company Share To 2021: Acute Market ReportsRD News MagBiosimulation is explained as a computer-aided mathematical simulation of biological processes and systems and hence is an integral part of systems biology. The main aim of Biosimulation is model-based prediction of the behavior and the dynamics of ...and more »

Emerging Metabolomics Consumption 2016: Global Market Research, Trends And Reviews Report - Medgadget.com (blog)

Thu, 23/06/2016 - 15:04
Emerging Metabolomics Consumption 2016: Global Market Research, Trends And Reviews ReportMedgadget.com (blog)The Global Metabolomics Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Metabolomics market. First, the report provides a basic overview of the Metabolomics industry including definitions, ...

Global Metabolomics Market to Reach 2500.0 million by 2020, Growing at CAGR of 25.0% by 2020 - Medgadget.com (blog)

Thu, 23/06/2016 - 01:23
Global Metabolomics Market to Reach 2500.0 million by 2020, Growing at CAGR of 25.0% by 2020Medgadget.com (blog)Metabolomics-Market Zion Research has published a new report titled “Metabolomics Market by Technology (Mass Spectrometry, Capillary Electrophoresis, High Performance Liquid Chromatography, Gas Chromatography, and Nuclear Magnetic Resonance ...

Pages